Opinion|Videos|May 14, 2024

Non-Statin Therapies: Cost Effectiveness and Clinical Evidence Gaps

The expert panel discusses the cost-effectiveness and clinical evidence gaps for non-statin therapies, including PCSK9 inhibitors, inclisiran, and bempedoic acid.


Latest CME